Once-daily Regimen With Envarsus® to Optimize Immunosuppression Management and Outcomes in Kidney Transplant Recipients
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Prednisone
Related studies linked through entity extraction aliases.
Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
Decitabine Plus R-CHOP in Diffuse Large B-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Safety and Pharmacokinetics Study of Niraparib Plus an Androgen Receptor-Targeted Therapy in Men With Metastatic Castration-Resistant Prostate Cancer (BEDIVERE)
- Status
- COMPLETED
- Phase
- PHASE1
Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE2
Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis
- Status
- TERMINATED
- Phase
- PHASE4
PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage
- Status
- UNKNOWN
- Phase
- PHASE2
Therapy of Adults Affected by Idiopathic Thrombocytopenic Purpura With Dexamethasone
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Phase I Trial of Apalutamide Plus Abiraterone Acetate, Docetaxel, and Prednisone in Patients With mCRPC
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Mercaptopurine Therapy in Ulcerative Colitis
- Status
- UNKNOWN
- Phase
- PHASE3
Effect of Oral Steroids on Skin Outcomes in Atopic Dermatitis
- Status
- TERMINATED
- Phase
- NA
Neoadjuvant And Adjuvant Abiraterone Acetate + Apalutamide Prostate Cancer Undergoing Prostatectomy
- Status
- COMPLETED
- Phase
- PHASE2
Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk B Acute Lymphoblastic Leukemia and Ph-Like TKI Sensitive Mutations
- Status
- COMPLETED
- Phase
- PHASE3
Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Serum FFA Desaturase Activity Index in Patients on High Dose Corticosteroids
- Status
- UNKNOWN
- Phase
- N/A
Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels
- Status
- COMPLETED
- Phase
- PHASE2
EDOCH Alternating With DHAP for New Diagnosed Younger MCL
- Status
- COMPLETED
- Phase
- PHASE4